Session Details

[O-24]Oral Session 24 Neuroimmunology 3 (Basic research)

Fri. May 23, 2025 10:15 AM - 11:45 AM JST
Fri. May 23, 2025 1:15 AM - 2:45 AM UTC
第01会場(大阪国際会議場5F 大ホール)
Chairs: Shinji Oki(Dept. of Immunol., National Institute of Neuroscience, NCNP, Japan), Jin Nakahara(Department of Neurology, Keio University School of Medicine, Japan)

[O-24-1]Fibronectin: a potential target to restore blood-brain barrier integrity in multiple sclerosis

Hideaki Nishihara1, Kinya Matsuo1, Jun Nagamatsu1, Yukinari Shindo1, Saya Fujiwara1, Miwako Fujisawa2, Britta Engelhardt2, Yusei Miyazaki3, Masaaki Niino3, Juichi Fujimori4, Ichiro Nakashima4, Masayuki Nakamori1 (1.Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine, Japan, 2.Theodor Kocher Institute, University of Bern, Switzerland, 3.National Hospital Organization Hokkaido Medical Center, Japan, 4.Tohoku Medical and Pharmaceutical University, Japan)

[O-24-2]Cytotoxic CD8 T Cell Response to EBV: Insights into EBV-Driven Mechanisms in Multiple Sclerosis

Shinji Ashida, Peter Kosa, Francisco Otaizo-carrasquero, Dan Sturdevant, Craig Martens, Jeffrey Cohen, Bibiana Bielekova (National Institutes of Health, USA)

[O-24-3]Neural repair and progression inhibition via modulation of microglia by effector regulatory T cells

Youwei Lin1,2, Takashi Yamamura1 (1.Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan, 2.Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan)

[O-24-4]Characteristic deposition patterns of complements in NMOSD, MOGAD, and MS

Yoshiki Takai1,2, Simon Hametner3, Christian Riedl3, Tatsuro Misu1, Kazuo Fujihara4, Masashi Aoki1, Romana Höftberger3 (1.Department of Neurology, Tohoku University Hospital, Japan, 2.Department of Pathology, Tohoku University Hospital, Japan, 3.Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Austria, 4.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Japan)

[O-24-5]Establishment of assay system for KLHL11 antibodies and results in autoimmune cerebellar ataxia

Shintaro Fujii1, Hiroaki Yaguchi1, Akihiko Kudo1, Katsuki Eguchi1, Taichi Nomura1, Hisashi Uwatoko1, Shinichi Shirai1, Ikuko Iwata1, Masaaki Matsushima1, Keiko Tanaka2, Makoto Yoneda3, Akio Kimura4, Yukihiro Hamada5, Yuta Fukumoto6, Yuko Yamagishi6, Yoshitaka Nagai6, Ichiro Yabe1 (1.Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan, 2.Department of Animal Model Development, Brain Research Institute, Niigata University, Japan, 3.Faculty of Nursing and Social Welfare Sciences, Fukui Prefectural University, Japan, 4.Department of Neurology, Gifu University Graduate School of Medicine, Japan, 5.Department of Neurology, Izumi City General Hospital, Japan, 6.Department of Neurology, Faculty of Medicine, Kindai University, Japan)

[O-24-6]BK channel activation has neuroprotective effects in NMOSD model mice via regulating astrocytes

Kotaro Iida1, Takuya Matsushita2, Satoshi Nagata1, Ezgi Ozdemir Takase1, Kaoru Kashu1, Takayuki Fujii1, Mitsuru Watanabe1, Katsuhisa Masaki1, Ryo Yamasaki1, Noriko Isobe1 (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Department of Neurology, Kochi Medical School, Kochi University, Japan)